It’s going to be a big week for Johnson & Johnson’s COVID-19 vaccine, which has hit pitfall after pitfall since its launch. European officials offered renewed ...

With COVID-19 cases mounting, India has equipped local drugmaker Bharat Biotech with government cash to rapidly scale up its vaccine output this year.  B...

Seagen and Astellas have stepped in the FDA fast lane to move Padcev into earlier bladder cancer treatment—and one step closer to the antibody-drug conjugate’s block...

This years’ Astellas cancer care challenge brought home the realities of the COVID-19 pandemic for cancer patients. Now in its fifth year, the C3 award submissions...

Just six months into its life span, fledgling biomanufacturer National Resilience is moving full speed ahead on its lofty expansion plans. After snaring a pair of co...

After drug regulators on both sides of the Atlantic revealed safety probes into Johnson & Johnson’s COVID-19 vaccine, U.S. officials are calling for an immediate...

Gilead Sciences has been exploring its antiviral remdesivir for COVID-19 in the outpatient setting, hoping to replicate the success seen in hospitalized patients. Bu...

Pharma continues to shine under the pandemic spotlight. The Global RepTrak 100 is the latest to mark the industry's image improvements—noted as the poll’s biggest ye...

India is one of the world's biggest manufacturers of drugs and vaccines, but that hasn't made it immune to COVID-19 supply instability. Now, the government is lockin...

Eli Lilly’s Retevmo is already approved to treat lung and thyroid cancers driven by alterations in the RET gene. Now, the Indianapolis pharma believes it has data to...